ImmunologybioRxivPreprint
CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung Cancer
A. Chow, F. Z. Uddin, L. Mangarin…·C. M. Rudin
This study identifies CD39 as a marker for tumor-reactive CD8 T cells in lung cancer, showing its association with clinical outcomes and response to immune checkpoint therapy.